Breaking News, Promotions & Moves

BASi Appoints COO

Oakley responsible for leading operations at BASi’s three sites in West Lafayette and Evansville, IN, and St. Louis, MO

By: Kristin Brooks

Managing Editor, Contract Pharma

D. Thomas Oakley has been appointed chief operating officer, BASi. Mr. Oakley will be responsible for leading operations among BASi’s three sites located in West Lafayette and Evansville, IN, and St. Louis, MO.

Mr. Oakley is a senior executive with more than 20 years of strategic and operational experience in the contract research industry. Most recently, he served as chief executive officer of Seventh Wave Laboratories, and joined BASi in July of last year when BASi acquired the operations of Seventh Wave.

Prior to Seventh Wave Laboratories, Mr. Oakley led DTO Associates and served as president and chief operating officer of MPI Research, president and chief executive officer of ChanTest Corp., and president and chief executive officer of Bridge Laboratories. He has also held leadership positions with the Sarah Cannon Research Institute and Covance.

“I have great confidence in Tom and his ability to lead and coordinate operations among our sites,” said Robert Leasure, Jr., BASi’s president and chief executive officer. “We have a talented and highly-capable team of site leaders, and Tom’s vast experience and mentorship is a tremendous asset to us as we continue to unify operations and grow the Company.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters